August 6, 2019 – Inflammatix Wins AACC’s Disruptive Technology Award For Its Rapid HostDx™ Tests

2019-08-06T15:48:57-07:00August 6th, 2019|

Burlingame, Calif., August 6, 2019  --- Inflammatix, a molecular diagnostics company that is reimagining diagnostics, announced today that it has received the American Association for Clinical Chemistry's (AACC) Disruptive Technology Award for its rapid HostDx™ tests, which read the immune system to improve diagnosis of acute infections and sepsis. The award was based on the company's presentation [...]

May 16, 2019 – Inflammatix Named a Finalist for AACC’s Disruptive Technology Award for Its Rapid HostDx™ Tests

2019-05-16T12:58:28-07:00May 16th, 2019|

Burlingame, Calif., May 16, 2019  --- Inflammatix announced today that it has been named a finalist for the American Association for Clinical Chemistry’s (AACC) Disruptive Technology Award  for its rapid HostDx™ tests, which read the immune system to improve diagnosis of acute infections and sepsis. Inflammatix is one of three finalists that will present its technology at the 71st [...]

October 4, 2018 – Inflammatix to Present New Data at IDWeek 2018 Demonstrating Ability to Perform HostDx™ Fever Test to Rapidly Distinguish Bacterial from Viral Infections Across Multiple Laboratory Platforms

2018-10-16T16:49:43-07:00October 4th, 2018|

Burlingame, Calif., October 4, 2018  --- Inflammatix today announced that it will present findings from two studies demonstrating the ability of its HostDx™ Fever test to distinguish bacterial from viral infections on multiple rapid laboratory platforms that can deliver results in under 30 minutes. The new data will be presented at the Infectious Diseases Society of [...]

April 10, 2018 – Inflammatix Named a Finalist in Fast Company’s 2018 World Changing Ideas Awards for Its Novel HostDx Tests

2018-04-10T09:55:32-07:00April 9th, 2018|

Burlingame, Calif., April 10, 2018  --- Inflammatix announced today that it has been named a finalist in Fast Company’s 2018 World Changing Ideas Awards for its novel HostDx™ tests, which read the immune system to tackle the global health problems of antibiotic resistance and sepsis. The annual award honors businesses, policies, projects and concepts that offer [...]